- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis shows that the financial resources of Dong-A Pharmaceutical Strategic Change And Threats are highly valuable as these help in investing into external opportunities that arise. These also help Dong-A Pharmaceutical Strategic Change And Threats in combating external threats.
- According to the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis shows that Dong-A Pharmaceutical Strategic Change And Threats's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Dong-A Pharmaceutical Strategic Change And Threats's products.
- According to the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Dong-A Pharmaceutical Strategic Change And Threats. These patents also provide Dong-A Pharmaceutical Strategic Change And Threats with licensing revenue when it licenses these patents out to other manufacturers.
- The Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis shows that Dong-A Pharmaceutical Strategic Change And Threats’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Dong-A Pharmaceutical Strategic Change And Threats. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis shows that the research and development at Dong-A Pharmaceutical Strategic Change And Threats is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Dong-A Pharmaceutical Strategic Change And Threats. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Dong-A Pharmaceutical Strategic Change And Threats are found to be rare according to the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Dong-A Pharmaceutical Strategic Change And Threats and inhibit competitive advantage. This means that the local food products result in competitive parity for Dong-A Pharmaceutical Strategic Change And Threats. As this resource is valuable, Dong-A Pharmaceutical Strategic Change And Threats can still make use of this resource.
- The employees of Dong-A Pharmaceutical Strategic Change And Threats are a rare resource as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Dong-A Pharmaceutical Strategic Change And Threats are a rare resource as identified by the Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Dong-A Pharmaceutical Strategic Change And Threats to use them without interference from the competition.
- The distribution network of Dong-A Pharmaceutical Strategic Change And Threats is a rare resource as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Dong-A Pharmaceutical Strategic Change And Threats. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Dong-A Pharmaceutical Strategic Change And Threats are costly to imitate as identified by the Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Dong-A Pharmaceutical Strategic Change And Threats provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Dong-A Pharmaceutical Strategic Change And Threats are also not costly to imitate as identified by the Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Dong-A Pharmaceutical Strategic Change And Threats by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Dong-A Pharmaceutical Strategic Change And Threats a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Dong-A Pharmaceutical Strategic Change And Threats are very difficult to imitate as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Dong-A Pharmaceutical Strategic Change And Threats is also very costly to imitate by competition as identified by the Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. This has been developed over the years gradually by Dong-A Pharmaceutical Strategic Change And Threats. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Dong-A Pharmaceutical Strategic Change And Threats are organised to capture value as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Dong-A Pharmaceutical Strategic Change And Threats.
- The Patents of Dong-A Pharmaceutical Strategic Change And Threats are not well organised as identified by the Dong-A Pharmaceutical Strategic Change And Threats VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Dong-A Pharmaceutical Strategic Change And Threats starts selling patented products before the patents expire.
- The distribution network of Dong-A Pharmaceutical Strategic Change And Threats is organised as identified by the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats. Dong-A Pharmaceutical Strategic Change And Threats uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Dong-A Pharmaceutical Strategic Change And Threats.
From the VRIO Analysis of Dong-A Pharmaceutical Strategic Change And Threats, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Dong-A Pharmaceutical Strategic Change And Threats is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Besho Adams
5.0
My experience with this service is mind-blowing. First, affordable prices made me feel free from the budget’s tension. Second, on-time delivery provided me peace. Third, this last and the most aching point for me is the content of the assignment. Thank you so much for providing all these advantages under one site.
Zhang Zason
5.0
The professor was surprised when he read the assignment. These guys are professional and did a good job. Thank you so much!
Michela Giuseppe
5.0
Meticulous paper delivered on the exact schedule and I’m very happy with this cheap essay writing service. Thanks a lot!
Huba Tibor
5.0
Highly recommended service for Finance coursework! I will surely use this service whenever I’ll be in trouble. Thanks a lot!
Next Articles
- Securitizing An Athlete's Future Income: The Vernon Davis Tracking Stock Vrio Analysis
- Patch AOL's Hyperlocal Experiment Vrio Analysis
- Creative Promotions Nigeria, Ltd Vrio Analysis
- Children Having Children: A Case Study Vrio Analysis
- Bug Busters Corporate Tattoo Initiative: Kicking The Hornet's Nest Without Getting Stung Vrio Analysis
- Ichitan Group And The Price War In Thailand's Ready To Drink Tea Market Vrio Analysis
- Panacea Specialty Chemicals: Why The New Corrosion Inhibitor Is Corroding Us? Vrio Analysis
- The Evolving Role Of Peer To Peer Lending: A New Financing Alternative Vrio Analysis
- Was Cooper Tire & Rubber Ripe For Sale? Vrio Analysis
- Electrical And Electronic Equipment Cluster In Thailand: Can Competitiveness Be Regained? Vrio Analysis
Previous Articles
- A Multidisciplinary Approach To Mitigating Antimicrobial Resistance Vrio Analysis
- Applying The Resource Based View Of The Firm To Qingdao, China Vrio Analysis
- Sweet Peas Stitchery: A Case Of A Start Up Merchandiser Part B Vrio Analysis
- Impairment Analysis: Comparison Of Impairment Of Long Lived Assets Between US GAAP And IFRS Vrio Analysis
- What Every College Student Should Know About Non Compete Agreements Vrio Analysis
- Revenue Recognition At Ingelheim Sustainability Consultants A Case Exploring The Effect Of The New Converged Standard Vrio Analysis
- The Coin Has Two Faces: Differences That Matter Vrio Analysis
- Making The Most Of Your Money: Evaluating Employee Retirement Plan Fund Performance Vrio Analysis
- The 'Ethics Cases' Case Vrio Analysis
- ID Fresh Food: A Compliment To Healthy Homemade Cooking Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!